Get access to our best features
Get Started
Subscribe
Israeli-Palestinian Conflict
2024 US Election
US Economy
Donald Trump
US Politics
Joe Biden
Republican Party
Baseball
US Crime
Abortion
Golf
Senate
Boston Marathon
Get access to our best features
Get Started
Published 2 years ago

What you need to know about possible new Alzheimer's drug

Summary by Ground News
Lecanemab shows a 27% reduction in cognitive decline compared with people on a placebo. There were side effects, including brain bleeds or swelling. The drug won't be considered for approval by the FDA until next year. Other medications are aimed at neuroprotective agents that can help safeguard nerve cells.

0 Articles

All
Left
Center
Right
The StatesmanThe Statesman

What you need to know about possible new Alzheimer's drug

Lecanemab showed some promise, but won't be the cure many are looking for.

2 years ago·Austin, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

AlzheimerAlzheimer
Trending Topics
Ground News logo
US
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble Newsletter
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc.
News
For You
Search
BlindspotLocal